Emergen Research Logo. The diabetic foot ulcer treatment market is expected to grow from an estimated USD 5.36 Billion in 2024 to USD 9.21 Billion in 2033, ...
RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified ...